# reload+after+2024-01-21 09:47:04.575157
address1§100 Columbia
city§Aliso Viejo
state§CA
zip§92656
country§United States
phone§949 521 7830
website§https://www.rxsight.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§RxSight, Inc., an ophthalmic medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
fullTimeEmployees§292
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Ronald M. Kurtz M.D.', 'age': 60, 'title': 'President, CEO & Director', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 1025471, 'exercisedValue': 0, 'unexercisedValue': 19159}, {'maxAge': 1, 'name': 'Ms. Shelley B. Thunen', 'age': 69, 'title': 'CFO & Assistant Secretary', 'yearBorn': 1954, 'fiscalYear': 2022, 'totalPay': 651355, 'exercisedValue': 0, 'unexercisedValue': 297356}, {'maxAge': 1, 'name': 'Dr. Ilya  Goldshleger Ph.D.', 'age': 48, 'title': 'Chief Operating Officer', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 657813, 'exercisedValue': 0, 'unexercisedValue': 748185}, {'maxAge': 1, 'name': 'Mr. Eric J. Weinberg', 'age': 62, 'title': 'Chief Commercial Officer', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 638897, 'exercisedValue': 0, 'unexercisedValue': 1936087}, {'maxAge': 1, 'name': 'Ms. Rebecca  Williston', 'title': 'Vice President of Accounting & Finance', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Matt  Haller Ph.D.', 'title': 'Chief Technology Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Alex  Huang', 'title': 'Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Roy  Freeman', 'title': 'Vice President of Marketing', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Caroline  Vaughn', 'title': 'Vice President of Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Scott  Gaines', 'title': 'Senior VP of Commercial Operations & Business Process', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§4
boardRisk§4
compensationRisk§8
shareHolderRightsRisk§8
overallRisk§6
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.193
priceToSalesTrailing12Months§17.274067
currency§USD
dateShortInterest§1702598400
forwardEps§-1.2
pegRatio§-1.2
exchange§NGM
quoteType§EQUITY
shortName§RxSight, Inc.
longName§RxSight, Inc.
firstTradeDateEpochUtc§1627651800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§07da8956-a5ad-3592-ab35-e9dc0189ee49
gmtOffSetMilliseconds§-18000000
targetHighPrice§42.0
targetLowPrice§32.0
targetMeanPrice§37.0
targetMedianPrice§36.0
recommendationMean§1.6
recommendationKey§buy
numberOfAnalystOpinions§7
quickRatio§7.767
grossMargins§0.56843
ebitdaMargins§-0.65650004
trailingPegRatio§None
